
AURORA CANNABIS INC
ACBNASDAQTrading Snapshot
- Day Range
- $3.47 β $3.51
- 52-Week Range
- β
- Volume
- $3.71B
- Avg Volume
- $4.10B
- Shares Outstanding
- 62.0M
- Next Earnings
- Sep 6, 2026
Fundamentals Snapshot
- Annual Revenue
- $321M
- Last Q Revenue
- $68M
- P/E Ratio
- β
- P/S Ratio
- 0.8x
- EPS (TTM)
- β
- Dividend Yield
- β
Why Investors Own ACB
- βHigh-growth profile β revenue up +1.3% YoY with expanding US Equity exposure.
- βHealthy economics β 34% gross margin and 23% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About AURORA CANNABIS INC
Aurora Cannabis Inc. is a leading company in the global cannabis industry, focusing on the cultivation, production, and sale of various cannabis and cannabis-derived products across Canada and internationally. Beyond its core product offerings, the company engages in a broad spectrum of related activities, including the design and engineering of facilities, cannabis breeding programs, research and development, and both wholesale and retail distribution channels. For medical users, Aurora provides a diverse selection of products such as different strains of dried cannabis, cannabis oils, capsules, and topical kits. Their inventory also includes ancillary items like vaporizers, vaporizer accessories, herb mills (specifically for CanniMed products), grinders, and secure containers for vaporizers. The company is actively involved in developing advanced medical cannabis products, with ongoing work on oral, topical, edible, and inhalable formulations. Furthermore, Aurora manages CanvasRX, a network of centers dedicated to cannabis counseling and community outreach. Its service portfolio extends to providing patient support, specialized design and construction services, and comprehensive analytical testing for cannabis products. Aurora Cannabis Inc. manages an extensive collection of brands, including Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and WMMC. The company's main corporate office is located in Edmonton, Canada.
Otter Score Breakdown
βAnalyst Ratings
βLatest News & Updates

Village Farms Is Undervalued As International Cannabis Revenue Hits Record Levels
Village Farms International's Q2 showed record international cannabis sales, facility expansion, cost cuts & a strong balance sheet. Read more about VFF stock.

12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Neuronetics (NASDAQ:STIM) shares moved upwards by 34.1% to $2.91 during Tuesday's regular session. The market value of their outstanding shares is at $151.0 million. As per the press release, Q2 earnings

Curaleaf Goes Public with Premium Acquisition Proposal for Aurora Cannabis
Curaleaf proposes to acquire Aurora Cannabis for $4 per share, offering a 45% premium to expand global operations.
Curaleaf Proposes $4.00/Share Offer For Aurora Cannabis
Proposed Offer reflects a 45% premium to Aurora's 30-day VWAP and a 110% premium to Aurora's 30-day VWAP excluding balance sheet cashΒ Provides Aurora shareholders with the opportunity to become owners of the

Aurora Cannabis Inc. 2027 Q1 - Results - Earnings Call Presentation
2026-08-08. The following slide deck was published by Aurora Cannabis Inc.

Aurora Cannabis Inc. (ACB:CA) Shareholder/Analyst Call Transcript
Aurora Cannabis Inc. (ACB:CA) Shareholder/Analyst Call August 7, 2026 1:00 PM EDTCompany ParticipantsMichael SingerNathalie Clark - Executive VP, General...